ENDRA Life Sciences (NDRA) Share-based Compensation: 2016-2021
Historic Share-based Compensation for ENDRA Life Sciences (NDRA) over the last 6 years, with Dec 2021 value amounting to $411,737.
- ENDRA Life Sciences' Share-based Compensation fell 24.19% to $411,737 in Q4 2021 from the same period last year, while for Dec 2021 it was $1.4 million, marking a year-over-year decrease of 31.29%. This contributed to the annual value of $571,924 for FY2024, which is 42.60% down from last year.
- ENDRA Life Sciences' Share-based Compensation amounted to $411,737 in Q4 2021, which was up 25.61% from $327,799 recorded in Q3 2021.
- ENDRA Life Sciences' 5-year Share-based Compensation high stood at $546,040 for Q2 2020, and its period low was $29,698 during Q1 2017.
- For the 3-year period, ENDRA Life Sciences' Share-based Compensation averaged around $412,206, with its median value being $381,167 (2019).
- Within the past 5 years, the most significant YoY rise in ENDRA Life Sciences' Share-based Compensation was 2,972.07% (2017), while the steepest drop was 62.04% (2017).
- Over the past 5 years, ENDRA Life Sciences' Share-based Compensation (Quarterly) stood at $402,443 in 2017, then dropped by 23.53% to $307,750 in 2018, then climbed by 23.23% to $379,247 in 2019, then spiked by 43.21% to $543,120 in 2020, then dropped by 24.19% to $411,737 in 2021.
- Its Share-based Compensation stands at $411,737 for Q4 2021, versus $327,799 for Q3 2021 and $383,087 for Q2 2021.